Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-05-28 @ 11:19 AM
Study NCT ID:
NCT05970302
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2023-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC
Sponsor:
Organization: